Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.17% |
| 2 | Financials | 6.59% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 4.26% |
| 5 | Consumer Discretionary | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Nektar Therapeutics
NKTR
$2.38B
| $4.27M | ﹤0.01% |
52,773
+32,146
| +156% | +$4.76M |
|
3052
Array Technologies
ARRY
$872M
| $4.26M | ﹤0.01% |
378,373
-105,236
| -22% | -$1.18M |
|
3053
PUT
GameStop
GME
$8.55B
| $4.26M | ﹤0.01% |
102,400
+40,000
| +64% | +$1.18M |
|
3054
Evolus
EOLS
$398M
| $4.26M | ﹤0.01% |
+379,982
| New | +$3.24M |
|
|
TLMDW
3055
CALL
DELISTED
SOC Telemed, Inc. Warrants
TLMDW
| $4.26M | ﹤0.01% |
5,258,000
+355,100
| +7% | +$187K |
|
3056
RLJ Lodging Trust
RLJ
$1.87B
| $4.26M | ﹤0.01% |
302,378
-714,195
| -70% | -$10M |
|
|
YALA
3057
Yalla Group
YALA
$840M
| $4.25M | ﹤0.01% |
948,808
+36,166
| +4% | +$209K |
|
|
AHRT
3058
AH Realty Trust
AHRT
$527M
| $4.25M | ﹤0.01% |
290,800
+70,324
| +32% | +$1.01M |
|
3059
Altimmune
ALT
$583M
| $4.25M | ﹤0.01% |
697,160
+588,302
| +540% | +$4.33M |
|
3060
Viavi Solutions
VIAV
$9.31B
| $4.25M | ﹤0.01% |
+263,969
| New | +$4.35M |
|
3061
Tootsie Roll Industries
TR
$2.96B
| $4.24M | ﹤0.01% |
136,529
-144,843
| -51% | -$4.32M |
|
|
SRRA
3062
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.24M | ﹤0.01% |
+132,187
| New | +$3.79M |
|
|
PWPPW
3063
CALL
DELISTED
Perella Weinberg Partners Warrant
PWPPW
| $4.22M | ﹤0.01% |
2,099,932
+687,986
| +49% | +$1.76M |
|
3064
Cable One
CABO
$254M
| $4.22M | ﹤0.01% |
2,881
+2,034
| +240% | +$3.1M |
|
3065
Lindsay Corp
LNN
$1.15B
| $4.21M | ﹤0.01% |
26,785
-113,000
| -81% | -$15.6M |
|
3066
iShares MSCI Brazil ETF
EWZ
$9.22B
| $4.2M | ﹤0.01% |
111,193
-113,907
| -51% | -$3.68M |
|
|
CNCE
3067
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.2M | ﹤0.01% |
1,245,412
-103,817
| -8% | -$329K |
|
3068
Seres Therapeutics
MCRB
$48.7M
| $4.2M | ﹤0.01% |
29,464
-33,760
| -53% | -$5.19M |
|
3069
Eagle Bancorp
EGBN
$849M
| $4.2M | ﹤0.01% |
73,579
-91,627
| -55% | -$5.47M |
|
3070
Reliance Steel & Aluminium
RS
$20.9B
| $4.19M | ﹤0.01% |
22,874
-138,407
| -86% | -$23.9M |
|
|
TLGY
3071
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $4.18M | ﹤0.01% |
+420,193
| New | +$4.17M |
|
|
AFMD
3072
DELISTED
Affimed
AFMD
| $4.18M | ﹤0.01% |
95,727
+18,691
| +24% | +$812K |
|
|
BFAC.U
3073
DELISTED
Battery Future Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BFAC.U
| $4.17M | ﹤0.01% |
415,000
-71,757
| -15% | -$718K |
|
3074
Xenon Pharmaceuticals
XENE
$6.02B
| $4.17M | ﹤0.01% |
136,326
+45,705
| +50% | +$1.37M |
|
3075
PUT
C4 Therapeutics
CCCC
$387M
| $4.17M | ﹤0.01% |
+171,700
| New | +$4.17M |
|
Similar funds
Millennium Management's Q1 2022 Portfolio in Review
As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Millennium Management's Q1 2022 filing shows 1,492 new, 2,451 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
- Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.